An inhibitor of MCT1 and MCT4
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Syrosingopine

Item No. 36402

Technical Information
Formal Name
(3β,16β,17α,18β,20α)-18-[[4-[(ethoxycarbonyl)oxy]-3,5-dimethoxybenzoyl]oxy]-11,17-dimethoxy-yohimban-16-carboxylic acid, methyl ester
CAS Number
84-36-6
Synonyms
  • NSC 77030
  • SU 3118
Molecular Formula
C35H42N2O11
Formula Weight
Purity
≥95%
Formulation
A solid
DMF: 2 mg/mlDMSO: Slightly solublePBS (pH 7.2): 0.3 mg/ml
λmax
212 nm
SMILES
COC([C@H]1[C@@]2([H])C[C@]3([H])C4=C(CCN3C[C@@]2([H])C[C@H]([C@@H]1OC)OC(C5=CC(OC)=C(C(OC)=C5)OC(OCC)=O)=O)C6=CC=C(OC)C=C6N4)=O
InChi Code
InChI=1S/C35H42N2O11/c1-7-46-35(40)48-31-26(42-3)12-18(13-27(31)43-4)33(38)47-28-14-19-17-37-11-10-22-21-9-8-20(41-2)15-24(21)36-30(22)25(37)16-23(19)29(32(28)44-5)34(39)45-6/h8-9,12-13,15,19,23,25,28-29,32,36H,7,10-11,14,16-17H2,1-6H3/t19-,23+,25-,28-,29+,32+/m1/s1
InChi Key
ZCDNRPPFBQDQHR-SSYATKPKSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Syrosingopine is an inhibitor of monocarboxylate transporter 1 (MCT1) and MCT4 (IC50s = 2,500 and 40 nM, respectively).1 It inhibits MCT-facilitated lactate export and decreases intracellular pH in HL-60 promyeloblast cells when used at a concentration of 10 µM. Syrosingopine (5 µM), in combination with metformin (Item No. 13118), decreases cell growth in HL-60 cells.2 Intravenous administration of syrosingopine (0.5 mg/kg) reduces heart norepinephrine levels, mean arterial pressure (MAP), and pulse rate in normotensive dogs.3 Formulations containing syrosingopine have been used in the treatment of hypertension.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Benjamin, D., Robay, D., Hindupur, S.K., et alDual inhibition of the lactate transporters MCT1 and MCT4 is synthetic lethal with metformin due to NAD+ depletion in cancer cells. Cell Rep. 25(11), 3047-3058 (2018).

    2. Benjamin, D., Colombi, M., Hindupur, S.K., et alSyrosingopine sensitizes cancer cells to killing by metformin. Sci. Adv. 2(12), e1601756 (2016).

    3. Orlans, F.B., Finger, K.F., and Brodie, B.B. Pharmacological consequences of the selective release of peripheral norepinephrine by syrosingopine (Su 3118). J. Pharmacol. Exp. Ther. 128, 131-139 (1960).